Drug Development Health Technology healthcare technology 
Digital Health Global
JANUARY 4, 2024
Koneksa’s innovative digital model aims to address limitations in existing functional status assessments by leveraging digital health technologies (DHTs) for both objective and self-reported outcomes. Chief Medical Officer, Koneksa. Chief Scientific Officer, Koneksa.
Digital Health Global
APRIL 25, 2024
This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., The study, led by principal investigator Nitin Ohri, M.D., Chief Medical Officer, Koneksa. “By
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
JUNE 13, 2023
“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.
Lloyd Price
DECEMBER 2, 2024
Nelson Advisors work with Healthcare Technology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Lloyd Price
NOVEMBER 8, 2024
The increasing adoption of digital health technologies, the growing importance of AI and ML, and the evolving regulatory landscape will continue to shape the deal landscape. Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Lloyd Price
JULY 15, 2024
Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.
Expert insights. Personalized for you.
88 
Let's personalize your content